STE: 10-K Risk Factor Changes

2023 vs 2022  ·  SEC EDGAR  ·  2026-07-05
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

3
New Risks
2
Removed
11
Modified
22
Unchanged
🟢 New in Current Filing The effects of geopolitical instability, including as a result of Russia’s invasion of Ukraine, may adversely affect us and create significant risks and uncertainties for our business, with the ultimate impact dependent on future developments, which are highly uncertain and unpredictable. 🔒
🟢 New in Current Filing Expectations relating to ESG considerations expose us to potential liabilities, increased costs, reputational harm and other adverse effects on our business. 🔒
🔴 No Match in Current Filing The current military conflict between Russia and Ukraine and its implications on U.S., Canadian and European Union relations with Russia could cause long term geopolitical and economic instability that may impact our future operating results. 🔒
🟢 New in Current Filing Our EO sterilization operations subject us to claims of liability and associated adverse effects. 🔒
🟡 Modified Current economic and political conditions make tax rules in any jurisdiction subject to significant change. 🔒
🟡 Modified We are subject to extensive regulatory requirements and must receive and maintain regulatory clearance or approval for many products and operations. Failure to receive or maintain, or delays in receiving, clearance or approvals may negatively impact our revenues, profitability, financial condition, or value. 🔒
🟡 Modified Changes in tax treaties and trade agreements could negatively impact our costs, results of operations and earnings per share. 🔒
🟡 Modified We may be adversely affected by global climate change or by existing and future legal, regulatory or market responses to such change. 🔒
🔴 No Match in Current Filing Our performance may suffer if we do not effectively manage our expanded operations. 🔒
🟡 Modified The integration of acquired businesses into STERIS may not be as successful as anticipated. 🔒
🟡 Modified A pandemic or similar public health crises, such as COVID-19, could have a material adverse impact on ability to staff our operations. 🔒
🟡 Modified STERIS has incurred and expects to incur significant transaction and related costs in connection with business acquisitions and dispositions, which may be in excess of those anticipated. 🔒
🟡 Modified We may fail to realize all of the anticipated benefits of an acquired business, or those benefits may take longer to realize than expected. 🔒
🟡 Modified We have recorded goodwill and other intangible assets that could become impaired and result in material non-cash changes to our results of operation in the future. 🔒
🟡 Modified We incurred a substantial amount of additional debt to complete the Cantel Medical acquisition. Our debt level may limit our financial and business flexibility. 🔒
🟡 Modified Past and future business acquisitions may not be as accretive to STERIS’s earnings per share and cash flow from operations per share, which may negatively affect the market price of STERIS Shares. 🔒
16 changes in this historical filing

Historical year-over-year comparisons (2023 vs 2022 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →